User:Lieve Ons

Patrick Schöffski

Biography

Patrick Schöffski, MD, MPH, is a board-certified internist, haematologist, and oncologist from Hannover, Germany, where he also received a master degree in public health at Hannover Medical School. He is the current head of the Department of General Medical Oncology and the Laboratory of Experimental Oncology at the University Hospitals Leuven, KU Leuven, Belgium. Until October 2009, he was secretary-general of the Executive Committee and Board of the European Organisation for Research and Treatment of Cancer (EORTC). He is also a member of the Board of Directors of the European Cancer Organisation (ECCO). He is also a member of many scientific societies including the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR), European Society for Medical Oncology (ESMO), German Society of Haematology and Oncology (DGHO), and Belgian Society for Medical Oncology (BSMO) and current board member of the Connective Tissue Oncology Society (CTOS).

Professor Schöffski’s main clinical interest is the treatment of solid tumors and lymphomas. He is involved in a large number of prospective clinical trials in various tumor types, including orphan malignancies, ranging from phase I-III. He leads an active phase I-team in Leuven, has a strong interest in multitumor phase II-screening studies, and runs complex clinical trials in the field of personalized oncology and registration studies in various malignancies. He coordinates translational research projects associated with new drug development and in diseases such as sarcoma, urogenital malignancies, and others. He has been involved in registrational trials of antineoplastic agents in a variety of solid tumors.

He was work package leader in the Connective Tissue Cancers Network (CONTICANET), a Network of Excellence funded by the European Commission’s Sixth Framework Programme. Professor Schöffski has published >180 papers in international peer-reviewed oncology journals. He is member of the advisory board of several pharmaceutical companies and independent advisor to academic organizations such as Cancéropôle Île-de-France, Paris, France, or the Ontario Institute for Cancer Research, Toronto, Canada. He acts as scientific chair of the Methods in Clinical Cancer Research Workshop series in Flims, Switzerland, organized by AACR, ECCO, ESMO and EORTC.

Internal links: http://nl.wikipedia.org/wiki/EORTC